Outcomes from IBD-associated and non-IBD-associated colorectal cancer: A Surveillance Epidemiology and end results medicare study

Diseases of the Colon and Rectum

Volumn 55, Issue 3, 2012, Pages 270-277

  Gearhart, Susan L ^a,c   Nathan, Hari ^a   Pawlik, Timothy M ^a   Wick, Elizabeth ^a   Efron, Jonathan ^a   Shore, Andrew D ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Colorectal cancer; Crohn's disease; Inflammatory bowel disease; Outcomes; Ulcerative colitis

Indexed keywords

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DEATH; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PROCTOCOLECTOMY; RETROSPECTIVE STUDY; UNITED STATES;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; ODDS RATIO; SEER PROGRAM; SURVIVAL RATE;

EID: 84859742031     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e318242620f     Document Type: Article

References (17)

1. Jess T, Loftus E, Velayos F, et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: A nested case-control study from Copenhagen County, Denmark and Olmsted County, Minnesota. Am J Gastroenterol. 2007;102:829-836. (Pubitemid 46496613)
2. Zisman T, Rubin D. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol. 2008;14:2662-2669.
3. Rhodes J, Campbell B. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Molecular Med. 2002;8:10-16. (Pubitemid 34044673)
4. Baars J, Looman C, Steyerberg E, et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: Results from a nationwide nested case-control study. Am J Gastroenterol. 2011;106:319-328.
5. Eaden J, Abrams K, Mayberry J. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut. 2001;48:526-535. (Pubitemid 32234798)
6. Bernstein C, Blanchard J, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: A population based study. Cancer. 2001;91:854-862. (Pubitemid 32173312)
7. Lakatos L, Mester G, Erdelyi Z, et al. Risk factors for ulcerative colitis- associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: Results of a population-based study. Inflamm Bowel Dis. 2006;12:205-211.
8. Winther K, Jess T, Langholz E, Munkholm P, Binder V. Longterm risk of cancer in ulcerative colitis: A population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol. 2004;2:1088-1095. (Pubitemid 40037640)
9. Kiran R, Khoury W, Church J, Lavery I, Fazio V, Remzi F. Colorectal cancer complicating inflammatory bowel disease. Ann Surg. 2010;252:330-335.
10. Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K. Ulcerative colitis-associated colorectal cancer shows poorer survival than sporadic colorectal cancer: A nationwide Japanese study. Inflamm Bowel Dis. 2011;17:802-808.
11. Jensen A, Larsen M, Gislum M, et al. Survival after colorectal cancer in patients with ulcerative colitis: A nationwide population- based Danish study. Am J Gastroenterol. 2006;101:1283-1287. (Pubitemid 43829994)
12. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: An overview. Med Care. 2002;40:26-35.
13. Wibmer A, Kroesen A, Grone J, et al. Predictors of permanent ileostomy after restorative proctocolectomy. Br J Surg. 2010;97: 1561-1566.
14. Paquette I, Kemp J, Finlayson S. Patient and hospital factors associated with use of sphincter-sparing surgery for rectal cancer. Dis Colon Rectum. 2010;53:115-120.
15. Dhir M, Montgomery E, Clockner S, et al. Epigenetic Regulation ofWNTsignaling pathway genes in inflammatory bowel disease (IBD) Associated Neoplasia. J Gastrointest Surg. 2008;12:1745-1753.
16. Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011;17:1966 -1970.
17. Lindgren R, Hallbook O, Rutegard J, Sjodahl R, Matthiessen P. What is the risk for a permanent stoma after low anterior resection of the rectum for cancer? A six-year follow-up of a multicenter trial. Dis Colon Rectum. 2011;54:51-57.